Learn More
Medchemexpress LLC TL13-112 | 2229037-19-6 | MFCD12922943 | >98.0% | 1002.6 | C49H60ClN9O10S | 10MG

Supplier: Medchemexpress LLC HY12391910MG
TL13-112 is a PROTAC research compound that targets anaplastic lymphoma kinase (ALK) for proteasomal degradation while inhibiting its kinase activity. It is a bifunctional molecule formed by conjugation of an ALK inhibitor with a cereblon-binding ligand and is used in cellular assays to study target degradation and downstream signaling.
- Potent ALK inhibition (IC50 = 0.14 nM).
- Induces degradation of Aurora A, FER, PTK2, and RPS6KA1 in cell assays.
- Bifunctional PROTAC conjugate of ceritinib and a cereblon-binding pomalidomide ligand.
- Chemical formula C49H60ClN9O10S; molecular weight ~1002.6 g/mol.
- Reported analytical purity ≥98% (HPLC).
- Intended for research use only; not for human or diagnostic applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.